EP2849744 - PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO [3,4,B]INDOL]-4-AMINE AND DULOXETINE [Right-click to bookmark this link] | |||
Former [2015/13] | PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO [3,4,B]INDOL]-4-AMINE AND ANTIDEPRESSANTS | ||
[2017/26] | Status | No opposition filed within time limit Status updated on 28.09.2018 Database last updated on 15.06.2024 | |
Former | The patent has been granted Status updated on 20.10.2017 | ||
Former | Grant of patent is intended Status updated on 15.06.2017 | ||
Former | Examination is in progress Status updated on 09.11.2016 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Grünenthal GmbH Zieglerstrasse 6 52078 Aachen / DE | [2015/13] | Inventor(s) | 01 /
FROSCH, Stefanie Beckerstrasse 49 52078 Aachen / DE | 02 /
LINZ, Klaus Nachtigallengrund 5 53359 Rheinbach / DE | 03 /
CHRISTOPH, Thomas Schilderstrasse 42 52080 Aachen / DE | [2015/13] | Application number, filing date | 13723003.3 | 16.05.2013 | [2017/47] | WO2013EP01464 | Priority number, date | EP20120003937 | 18.05.2012 Original published format: EP 12003937 | [2015/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013170965 | Date: | 21.11.2013 | Language: | EN | [2013/47] | Type: | A1 Application with search report | No.: | EP2849744 | Date: | 25.03.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.11.2013 takes the place of the publication of the European patent application. | [2015/13] | Type: | B1 Patent specification | No.: | EP2849744 | Date: | 22.11.2017 | Language: | EN | [2017/47] | Search report(s) | International search report - published on: | EP | 21.11.2013 | Classification | IPC: | A61K31/407, A61K31/381, A61K31/5375, A61K45/06, A61P29/00, A61P25/08, A61P25/24, A61P25/22 | [2015/13] | CPC: |
A61K31/407 (EP,CN,US);
A61K31/381 (EP,CN,US);
A61K31/5375 (EP,CN,US);
A61K45/06 (EP,CN,US);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/08 (EP);
A61P25/22 (EP);
| C-Set: |
A61K31/381, A61K2300/00 (US,CN,EP);
A61K31/407, A61K2300/00 (CN,EP,US);
A61K31/5375, A61K2300/00 (US,CN,EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/13] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT (1R,4R)-6'-FLUOR-N,N-DIMENTHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXAN-1,1'-PYRANO[3,4,B]INDO]-4-AMIN UND DULOXETIN | [2017/26] | English: | PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO [3,4,B]INDOL]-4-AMINE AND DULOXETINE | [2017/26] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA (1R,4R)-6'-FLUORO-N,N-DIMÉTHYL-4-PHÉNYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE ET DE LA DULOXETINE | [2017/26] |
Former [2015/13] | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT (1R,4R)-6'-FLUOR-N,N-DIMENTHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXAN-1,1'-PYRANO[3,4,B]INDO]-4-AMIN UND ANTIDEPRESSIVA | ||
Former [2015/13] | PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO [3,4,B]INDOL]-4-AMINE AND ANTIDEPRESSANTS | ||
Former [2015/13] | COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA (1R,4R)-6'-FLUORO-N,N-DIMÉTHYL-4-PHÉNYL-4',9'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE ET DES ANTIDÉPRESSEURS | Entry into regional phase | 18.12.2014 | National basic fee paid | 18.12.2014 | Designation fee(s) paid | 18.12.2014 | Examination fee paid | Examination procedure | 18.12.2014 | Examination requested [2015/13] | 17.06.2015 | Amendment by applicant (claims and/or description) | 15.07.2016 | Despatch of a communication from the examining division (Time limit: M04) | 04.11.2016 | Reply to a communication from the examining division | 13.06.2017 | Communication of intention to grant the patent | 12.10.2017 | Fee for grant paid | 12.10.2017 | Fee for publishing/printing paid | 12.10.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.07.2016 | Opposition(s) | 23.08.2018 | No opposition filed within time limit [2018/44] | Fees paid | Renewal fee | 12.05.2015 | Renewal fee patent year 03 | 10.05.2016 | Renewal fee patent year 04 | 10.05.2017 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 22.11.2017 | MK | 22.11.2017 | SM | 22.11.2017 | [2020/34] |
Former [2020/31] | MK | 22.11.2017 | |
SM | 22.11.2017 | ||
Former [2018/40] | SM | 22.11.2017 | Cited in | International search | [Y]WO2005066183 (GRUENENTHAL GMBH [DE], et al) [Y] 1-15 * claims 1, 18 *; | [Y]US2007004795 (SESHA RAMESH [US]) [Y] 1-15 * the whole document *; | [YD]US2008125475 (LINZ KLAUS [DE], et al) [YD] 1-15 * paragraph [0113]; claims 5, 21-22, 32, 34-37; compound A4 *; | [Y]US2008261984 (HUGHES BERNADETTE [GB], et al) [Y] 1-15* the whole document *; | [YD]US2011319440 (HINZE CLAUDIA [DE], et al) [YD] 1-15 * claims 20-22; compound 25 * | by applicant | US4389393 | US4612008 | US4765989 | US4783337 | US5330761 | US5399362 | US5455046 | US5472711 | WO2004043967 | WO2008040481 | - Textbook of Drug Design and Discovery, TAYLOR AND FRANCIS, (2002), pages 410 - 458 | - PAIN, (1992), vol. 50, pages 355 - 63 | - SCHR6DER ET AL., EUR J PAIN, (2010), vol. 14, page 814 |